Biobanking residual tissues

Human Genetics

Volumn 130, Issue 3, 2011, Pages 357-368

  Riegman, Peter H J ^a   Van Veen, Evert Ben ^b  

^a JOSEPHINE NEFKENS INSTITUTE   (Netherlands)

^b Medlaw Consult   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BIOBANK; BIOETHICS; CLINICAL DATA REPOSITORY; CONFIDENTIALITY; HEALTH CARE FACILITY; HUMAN; INFORMED CONSENT; MEDICAL RESEARCH; PATIENT PREFERENCE; PRIORITY JOURNAL; REVIEW; TRANSLATIONAL RESEARCH; ETHICS; FROZEN SECTION; INTERNATIONAL COOPERATION; LEGAL ASPECT; NOMENCLATURE; PATHOLOGY; POLICY; RESEARCH;

PARAFFIN;

FROZEN SECTIONS; HUMANS; INFORMED CONSENT; INTERNATIONAL COOPERATION; PARAFFIN EMBEDDING; PATHOLOGY, CLINICAL; PATIENT PREFERENCE; POLICY; RESEARCH; TERMINOLOGY AS TOPIC; TISSUE BANKS; TRANSLATIONAL RESEARCH;

EID: 80053334174     PISSN: 03406717     EISSN: 14321203     Source Type: Journal    
DOI: 10.1007/s00439-011-1074-x     Document Type: Review

References (78)

1. Allen J, McNamara B (2011) Reconsidering the value of consent in biobank research. Bioethics 2011(25):155-166
2. Al-Shahi R, Vousden C, Warlow C, Scottisch Intracranial Vasculkar Malformation Study Steering Committee (2005) Bias from requiring explicit consent from all participants in observational research: prospective, population based study. BMJ 331(7522):942
3. Bates S (2010) Progress towards personalized medicine. Drug Discov Today 15:115-120
4. Belgian Act (2008) Wet inzake het verkrijgen en het gebruik van menselijk lichaamsmateriaal met het oog op de geneeskundige toepassing op de mens of het wetenschappelijk onderzoek, as passed by the Parliament of Belgium and given Royal Assent in December 2008, art. 20.2
5. Bergkamp L (1988) Het proefdier mens, de normering en regulering van medische experimenten met mensen, Alphen aan den Rijn: Samson Uitgeverij
6. Bevilacqua G, Bosman F, Dassesse T, Höfler H, Janin A, Langer R, Larsimont D, Morente MM, Riegman P, Schirmacher P, Stanta G, Zatloukal K, Caboux E, Hainaut P (2010) The role of the pathologist in tissue banking: European Consensus Expert Group Report. Virchows Arch 456:449-454
7. Bovenberg JA (2006) Property rights in blood, genes and data, naturally yours?. Martinus Nijhoff Publishers, Leiden
8. Braun R, Rowe W, Schaefer C, Zhang J, Buetow K (2009) Needles in the haystack: identifying individuals present in pooled genomic data. PLoS Genet 5:e1000668. doi:10.1371/journal.pgen.1000668
9. Brody BA (1998) The ethics of biomedical research: an international perspective. OUP, New York
10. Campbell AV (2007) The ethical challenges of genetic databases: Safeguarding altruism and trust. King's Law J 18:227-245
11. Campbell AV (2011) Commentary: autonomy revisited-a response to H. Haker. J Int Med 269:380-382
12. Charter (2007) Charter of Fundamental Rights of the European Union (2007/C 303/01) art. 35
13. Council for International Organizations of Medical Sciences (CIOMS) (2009) International Ethical Guidelines for Epidemiological Studies, Geneva
14. Council of Europe (CoE) (2006) Recommendation Rec 4 of the Committee of Ministers to member states on research on biological materials of human origin (adopted by the Committee of Ministers on 15th March 2006)
15. Curren L, Boddington P, Gowans H, Hawkins N, Kanellopoulou N, Kaye J, Melham K (2010) Identifiability genomics and UK data protection law. Eur J Health Law 17:329-344
16. den Exter AP (ed) (2008) International health law. Solidarity and justice in health care. Maklu, Apeldoorn
17. Diamandis M, White NM, Yousef GM (2010) Personalized medicine: marking a new epoch in cancer patient management. Mol Cancer Res 8:1175-1187
18. Dressler LG (2009) Disclosure of research results from cancer genomic studies: state of the science. Clin Cancer Res 15:4270-4276
19. Elger BS, Caplan AL (2006) Consent and anonymization in research involving biobanks. EMBO Reports 7(7):661-666
20. European Commission (2001) The future of health care and care for the elderly: guaranteeing accessibility, quality and financial viability, COM (2001) 723 final
21. Faunce A (2005) Pilgrims in medicine: conscience, legalism and human rights, Kluwer Law International, The Netherlands
22. FEDERA (2011) Gedragscode Goed Gebruik (Gedragscode verantwoord omgaan met lichaamsmateriaal ten behoeve van medisch-wetenschappelijk onderzoek)
23. Foekens JA, Wang Y, Martens JWM, Berns EMJJ, Klijn JGM (2008) The use of genomic tools for the molecular understanding of breast cancer and to guide personolized medicine. Drug Discov Today 13:481-487
24. Follesdal A, Wessel RA, Wouters J (ed) (2008) Multilevel regulation and the EU: the interplay between global, European and national normative processes, Martinus Nijhoff Publishers, Leiden
25. Forsberg JS, Eriksson S, Hansson MG (2010) Changing defaults in biobank research could save lives too. Eur J Epidemiol 25:65-68
26. Fortier I, Burton PR, Robson PJ, Ferretti V, Little J, L'Heureux F, Deschênes M, Knoppers BM, Doiron D, Keers JC, Linksted P, Harris JR, Lachance G, Boileau C, Pedersen NL, Hamilton CM, Hveem K, Borugian MJ, Gallagher RP, McLaughlin J, Parker L, Potter JD, Gallacher J, Kaaks R, Liu B, Sprosen T, Vilain A, Atkinson SA, Rengifo A, Morton R, Metspalu A, Wichmann HE, Tremblay M, Chisholm RL, Garcia-Montero A, Hillege H, Litton JE, Palmer LJ, Perola M, Wolffenbuttel BH, Peltonen L, Hudson TJ (2010) Quality, quantity and harmony: the DataSHaPER approach to integrating data across bioclinical studies. Int J Epidemiol 39:1383-1393
27. Goodson ML, Vernon BG (2004) A study of public opinion on the use of tissue samples from living subjects for clinical research. J Clin Pathol 57:136-138
28. Hoedemaker R, Gordijn B, Pijnenburg M (2007) Solidarity and justice as guiding principles in genomics research. Bioethics 21(6):342-350 (Pubitemid 46854981)
29. Homer N, Szelinger S, Redman M, Duggan D, Tembe W, Muehling J, Pearson JV, Stephan DA, Nelson SF, Craig DW (2008) Resolving individuals contributing trace amounts of DNA to highly complex mixtures using high-density SNP genotyping microarrays. PloS Genet 4:e1000167. doi:10.1371/journal.pgen.1000167
30. International Conference on Harmonization (2007) Definitions for genomic biomarkers, pharmacogenomics, pharmacogenetics, genomic data and sample coding categories, E15, step 4 version
31. Ioannidis JPA (2009) Population-Wide Generalizability of Genome-Wide Discovered Associations. JNCI 101(19):1297-1299
32. ISO (International Organization for Standardization, Health informatics) (2008) Pseudonymization ISO/TS 25237:2008. ISO, Geneva
33. Jacobsen SJ, Xia Z, Campion ME et al (1999) Potential effect of authorization bias on medical record research. Mayo Clin Proc 74(4):330-338 (Pubitemid 29162532)
34. Janssens AC, van Duijn CM (2008a) Genome-based prediction of common diseases: advances and prospects. Hum Mol Genet 17:R166-R173
35. Janssens ACJW, van Duijn CM (2008b) Genome-based prediction of common diseases: advances and prospects. Hum Mol Genet 17:R166-R173
36. Jusilahti P, Salomaa V, Kuulasmaa K et al (2005) Total and cause specific mortality among participants and non-participants of population based surveys: a comprehensive follow-up of 54372 Finnish men and women. J Epedimiol Commun Health 59:310-315 (Pubitemid 40460584)
37. Kaphingst KA, Janoff JM, Harris LN, Emmons KM (2006) Views of female breast cancer patients who donated biologic samples regarding storage and use of samples for genetic research. Clin Genet 69:393-398
38. Kettis-Lindblad A et al (2005) Genetic research and donation of tissue samples to biobanks. What do potential sample donors in the Swedish general public think? Eur J Public Health 16(4):433-440 (Advanced access published online October 2005) (Pubitemid 44310264)
39. Knoppers BM, Chadwick R (2005) Human genetic research: emerging trends in ethics. Nat Rev Genet 6(1):75-79 (Pubitemid 39657899)
40. Knoppers BM, Saginur M (2005) The Babel of genetic data terminology. Nat Biotechnol 23:8
41. Knoppers BM, Abdul MH, Bédard K (2007) Genomic Databases and International Collaboration, 18 KLJ, pp 291-311
42. Lévesque E, Fraser W, Knoppers BM (2009) Consent to research: exceptional situations. GenEdit 7(3):1-12
43. Lowrance WW, Collins FS (2007) Ethics identifiability in genomic research. Science 317:600-602
44. Mancini J et al (2010) Consent for biobanking: assessing the understanding and views of cancer patients. JNCI 103:1-4
45. Mascalzoni D, Hicks A, Pramstaller P, Wjst M (2008) Informed consent in the genomics era. PLoS Med 5:e192. doi:10.1371/journal.pmed.0050192
46. Melas P, Sjöholm LK, Forsner T et al (2010) Examining the public refusal to consent to DNA biobanking: empirical data from a Swedish population-based study. J Med Ethics 36:93-98
47. Mello MM, Wolf LE (2010) The Havasupai Indian tribe case-lessons for research involving stored biologic samples. N Engl J Med 363:204-207
48. Mezuk B, Eaton WW, Zandi P (2008) Participant characteristics that influence consent for genetic research in a population-based survey: the baltimore epidemiologic catchment area follow-up. Community Genet 11:171-178 (Pubitemid 351465621)
49. Mills FJ, Brooks A (2010) Information systems for Biobanks/ Biorepositories: handling information associated with Compliant Sample Management. Biopreservation Biobanking 8:163-165. doi:10.1089/bio.2010.8310
50. Moore HM, Compton C, Alper J, Vaught JB (2011) International approaches to advancing biospecimen science. Cancer Epidemiol Biomarkers Prev. doi:10.1158/1055-9965.EPI-11-0021
51. Nietfeld JJ (2007) What is anonymous (letter). EMBO Reports 8(6):518
52. Nietfeld JJ, Sugarman J, Litton JE (2011) The Bio-PIN: a concept to improve biobanking. Nat Rev Cancer 11:303-308
53. O'Neill O (2002) Autonomy and trust in bioethics. CUP, Cambridge
54. OECD (2009) Guidelines for human biobanks and genetic research databases http://www.oecd.org/sti/biotechnology/hbgrd Accessed April 2011
55. Ohm P (2010) broken promises of privacy: responding to the surprising failure of anonymization (August 13, 2009). UCLA Law Rev vol 57, p 1701 U of Colorado Law Legal Studies Research Paper No. 9-12. Available at SSRN: http://ssrn.com/abstract=1450006
56. Oosterhuis JW, Coebergh J, van Veen EB (2003) Tumor banks, well guarded treasures in the interests of patients. Nat Rev Cancer 3:73-77
57. Ploem MC (2010) Gegeven voor de wetenschap; Regulering van onderzoek met gegevens, lichaamsmateriaal en biobanken, in Wetenschappelijk onderzoek in de zorg: Preadvies 2010, Vereniging voor Gezondheidsrecht, Den Haag, SDU: 117-210
58. Plomer A (2005) The law and ethics of medical research: international bioethics and human rights. Cavendish Publishing, London
59. Rathenau Instituut (2009) Nader gebruik nader onderzocht: zeggenschap over lichaamsmateriaal (Technology Assessment), Rathenau Instituut Den Haag
60. Riegman PHJ, de Jong BWD, Llombart-Bosch A (2010) The Organization of European Cancer Institute Pathobiology Working Group and its support of European biobanking infrastructures for translational cancer research. Cancer Epidemiol Biomarkers Prev 19:923-926
61. SAS 70 (Statement on Auditing Standards (SAS) No. 70 (see http://www.sas70.com)
62. Swierstra T (2004) Een essay over nader gebruik van lichaamsmateriaal ten behoeve van genomics onderzoek, Nederlandse Vereniging voor Bio-Ethiek Groningen
63. The Academy of Medical Sciences (2011) A new pathway for the regulation and governance of health research a report from the Academy of Medical Sciences. The Academy of Medical Sciences, London
64. The International Cancer Genome Consortium (2010) International network of cancer genome projects. Nature 15 464:993-998
65. Trouet C (2003) Van lichaam naar lichaamsmateriaal, Intersentia Antwerpen
66. Unesco (2005) The Universal Declaration on Bioethics and Human Rights, adopted by UNESCO in October 2005
67. van der Valk T (2010) Zeggenschap over lichaamsmateriaal: suggesties vanuit Europa. TvGR 7:562
68. van Leeuwen E (2008) Ethiek van medisch-wetenschappelijk onderzoek: informed consent en de therapeutische misconceptie. NTvG 12:679-683 (Pubitemid 351448823)
69. van Veen EB (2008) Obstacles to European research projects with data and tissue: solutions and further challenges. Eur J Cancer 44:1438-1450
70. van Veen EB, Riegman PH, Dinjens WN, Lam KH, Oomen MH, Spatz A, Mager R, Ratcliffe C, Knox K, Kerr D, van Damme B, van de Vijver M, van Boven H, Morente MM, Alonso S, Kerjaschki D, Pammer J, Lopez-Guerrero JA, Llombart Bosch A, Carbone A, Gloghini A, Teodorovic I, Isabelle M, Passioukov A, Lejeune S, Therasse P, Oosterhuis JW (2006) TuBaFrost 3: regulatory and ethical issues on the exchange of residual tissue for research across Europe. Eur J Cancer 42:2914-2923 (Pubitemid 44767664)
71. Vaught J, Kelly A, Hewitt R (2010) A review of International Biobanks and Networks: success factors and key benchmarks. Biopreservation Biobanking 7:143-150. doi:10.1089/bio.2010.0003
72. Vermeulen E, Schmidt MK, Aaronson NK, Kuenen M, van der Valk P, Sietses C, van den Tol P, van Leeuwen FE (2009) Opt-out plus, the patients' choice: preferences of cancer patients concerning information and consent regimen for future research with biological samples archived in the context of treatment. J Clin Pathol 62:275-278
73. Wendler D (2006) One time general consent for research on biological samples. BMJ 332:544-547 (Pubitemid 44364375)
74. Wolf SH, Rothemich SF, Johnson RE, Marsland DW (2000) Selection bias from requiring patients to give consent to examine data for health services research. Arch Fam Med 9(10):1111-1118 (Pubitemid 32014707)
75. Wolfson M et al (2010) DataSHIELD: resolving a conflict in contemporary bioscience-performing a pooled analysis of individual-level data without sharing the data. Int J Epidemiol 39:1372-1382. doi:10.1093/ije/dyq111
76. Working Party (2007) Opinion 4/2007 on the concept of personal data, Article 29 Data Protection Working Party, Brussels 2007: 0124807/EN, WP 136
77. World Medical Association. Declaration of Helsinki (2008) article A.6, WMA
78. Yassin R, Lockhart N, González del Riego M, Pitt K, Thomas JW, Weiss L, Compton C (2010) Custodianship as an ethical framework for biospecimen-based research. Cancer Epidemiol Biomarkers Prev 19:1012-1015